Drug Discovery Outsourcing Market By Application: Research Services, Preclinical Development, By End-Use: Pharmaceutical Companies, Biotech Startups, By Region: North America, Europe, Asia Pacific, Segment Forecasts: 2024 - 2030
Drug Discovery Outsourcing Market Trends
The drug discovery outsourcing market was valued at USD 27.2 billion in 2024 and is projected to grow at a CAGR of 11.5% from 2025 to 2030. The outsourcing of research services is becoming increasingly common as pharmaceutical companies seek to reduce costs and enhance efficiency.
Product Insights
Research services accounted for the largest market share in 2024, contributing 63.6% of total revenue, as companies seek specialized expertise in drug discovery. Preclinical development applications are also expanding, reflecting the increasing complexity of drug development processes.
End-Use Insights
Pharmaceutical companies were the largest end-users in 2024, holding a 70.2% market share, as they leverage outsourcing to focus on core competencies. Biotech startups are also increasingly adopting outsourcing strategies to accelerate their drug development efforts.
Regional Insights
North America dominated the drug discovery outsourcing market with a 50.6% share in 2024, supported by a strong pharmaceutical ecosystem and high demand for outsourced services. The Asia Pacific region is expected to witness substantial growth, with a CAGR of 12.1%, driven by rising outsourcing trends.
GET A FREE SAMPLE
This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.